APA (7th ed.) Citation

Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., . . . Manegold, C. (2010). Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: Results from a randomised phase III trial (AVAiL). Annals of oncology, 21(9), . https://doi.org/10.1093/annonc/mdq020

Chicago Style (17th ed.) Citation

Reck, Martin, et al. "Overall Survival with Cisplatin-gemcitabine and Bevacizumab or Placebo as First-line Therapy for Nonsquamous Non-small-cell Lung Cancer: Results from a Randomised Phase III Trial (AVAiL)." Annals of Oncology 21, no. 9 (2010). https://doi.org/10.1093/annonc/mdq020.

MLA (9th ed.) Citation

Reck, Martin, et al. "Overall Survival with Cisplatin-gemcitabine and Bevacizumab or Placebo as First-line Therapy for Nonsquamous Non-small-cell Lung Cancer: Results from a Randomised Phase III Trial (AVAiL)." Annals of Oncology, vol. 21, no. 9, 2010, https://doi.org/10.1093/annonc/mdq020.